Dandan Sheng

机构：Central South University, Second Affiliated Hospital of Nanjing Medical University, Xiangya Hospital Central South University · ORCID：0000-0002-8613-1583

发表论文 67 篇 · 总被引 2223 次 · h-index 22

代表论文

PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway (2023 · Signal Transduction and Targeted Therapy · 被引 130)
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization (2022 · Journal for ImmunoTherapy of Cancer · 被引 79)
Doxorubicin-liposome combined with clodronate-liposome inhibits hepatocellular carcinoma through the depletion of macrophages and tumor cells (2022 · International Journal of Pharmaceutics · 被引 24)
LPS/Bcl3/YAP1 signaling promotes Sox9+HNF4α+ hepatocyte-mediated liver regeneration after hepatectomy (2022 · Cell Death and Disease · 被引 20)
Aurora A–mediated pyruvate kinase M2 phosphorylation promotes biosynthesis with glycolytic metabolites and tumor cell cycle progression (2022 · Journal of Biological Chemistry · 被引 15)
The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials (2023 · Frontiers in Pharmacology · 被引 11)